Preferred stock, shares authorized (in shares)

[Table of Contents](#ia12bad69886c4075b7558d5239cbff30_7)PART IFINANCIAL INFORMATION  
Item 1. Financial Statements.CENTENE CORPORATION AND SUBSIDIARIESCONSOLIDATED BALANCE SHEETS(In millions, except shares in thousands and per share data in dollars)

|  |  |  |  |  |  |  |  |  |  |  |  |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
|  |  |  |  |  |  |  |  |  |  |  |  |
|  | March 31, 2022 |  | December 31, 2021 |
|  | (Unaudited) |  |  |
| ASSETS |   |  |   |
| Current assets: |   |  |   |
| Cash and cash equivalents | $ | 11,237  |  |  | $ | 13,118  |  |
| Premium and trade receivables | 16,169  |  |  | 12,238  |  |
| Short-term investments | 1,668  |  |  | 1,539  |  |
| Other current assets | 2,036  |  |  | 1,602  |  |
| Total current assets | 31,110  |  |  | 28,497  |  |
| Long-term investments | 14,129  |  |  | 14,043  |  |
| Restricted deposits | 1,210  |  |  | 1,068  |  |
| Property, software and equipment, net | 3,583  |  |  | 3,391  |  |
|  |  |  |  |
| Goodwill | 20,903  |  |  | 19,771  |  |
| Intangible assets, net | 8,138  |  |  | 7,824  |  |
| Other long-term assets | 3,828  |  |  | 3,781  |  |
| Total assets | $ | 82,901  |  |  | $ | 78,375  |  |
| LIABILITIES, REDEEMABLE NONCONTROLLING INTERESTS AND STOCKHOLDERS’ EQUITY |  |  |   |
| Current liabilities: |   |  |   |
| Medical claims liability | $ | 16,259  |  |  | $ | 14,243  |  |
| Accounts payable and accrued expenses | 9,980  |  |  | 8,493  |  |
| Return of premium payable | 2,628  |  |  | 2,328  |  |
| Unearned revenue | 526  |  |  | 434  |  |
| Current portion of long-term debt | 292  |  |  | 267  |  |
| Total current liabilities | 29,685  |  |  | 25,765  |  |
| Long-term debt | 18,640  |  |  | 18,571  |  |
| Deferred tax liability | 1,292  |  |  | 1,407  |  |
| Other long-term liabilities | 5,854  |  |  | 5,610  |  |
| Total liabilities | 55,471  |  |  | 51,353  |  |
| Commitments and contingencies |  |  |  |
| Redeemable noncontrolling interests | 117  |  |  | 82  |  |
| Stockholders’ equity: |   |  |   |
| Preferred stock, $0.001 par value; authorized 10,000 shares; no shares issued or outstanding at March 31, 2022 and December 31, 2021 | —  |  |  | —  |  |
| Common stock, $0.001 par value; authorized 800,000 shares; 605,925 issued and 584,854 outstanding at March 31, 2022, and 602,704 issued and 582,479 outstanding at December 31, 2021 | 1  |  |  | 1  |  |
| Additional paid-in capital | 19,830  |  |  | 19,672  |  |
| Accumulated other comprehensive earnings | (485) |  |  | 77  |  |
| Retained earnings | 8,988  |  |  | 8,139  |  |
| Treasury stock, at cost (21,071 and 20,225 shares, respectively) | (1,165) |  |  | (1,094) |  |
| Total Centene stockholders’ equity | 27,169  |  |  | 26,795  |  |
| Nonredeemable noncontrolling interest | 144  |  |  | 145  |  |
| Total stockholders’ equity | 27,313  |  |  | 26,940  |  |
| Total liabilities, redeemable noncontrolling interests and stockholders’ equity | $ | 82,901  |  |  | $ | 78,375  |  |

The accompanying notes to the consolidated financial statements are an integral part of these statements. 1
